Literature DB >> 5061315

Polyadenylic-polyuridylic acid, an adjunct to surgery in the treatment of spontaneous mammary tumors in C3H-He mice and transplantable melanoma in the hamster.

F Lacour, A Spira, J Lacour, M Prade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5061315

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.).

Authors:  J Lacour; A Laplanche; T Delozier; J Berlie; N Mourali; J P Julien; C De Gislain; M Namer; J C Petit; V Denis
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

2.  Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U).

Authors:  S K Singh; R L Marquet; D L Westbroek; J Jeekel
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 3.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required.

Authors:  P H Bick; G Möller
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

Review 5.  Harnessing the immune system in the battle against breast cancer.

Authors:  Elizabeth S Nakasone; Sara A Hurvitz; Kelly E McCann
Journal:  Drugs Context       Date:  2018-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.